SCHEMBL629781

SCHEMBL629781

CCCCN(CC)C1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADH1A P07327 4/20 0.42
CYP1A2 P05177 1/20 0.41
ADH1C P00326 3/20 0.41
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
KMT2A Q03164 2/20 0.35
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
MEN1 O00255 1/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
GRIN2B Q13224 1/20 0.33
ADH4 P08319 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22536991 1.00 ADH1A (0.42) ADH1ACYP1A2ADH1CDRD2DRD4
Hydrochloric Acid SCHEMBL7936896 0.98 ADH1A (0.41) ADH1ACYP1A2ADH1CDRD2DRD4
SCHEMBL3375793 0.98 ADH1A (0.41) ADH1ACYP1A2ADH1CDRD2DRD4
SCHEMBL24438349 0.94 ADH1A (0.41) ADH1ACYP1A2ADH1CDRD2DRD4
SCHEMBL4814659 0.92 ADH1A (0.43) ADH1ACYP1A2ADH1CDRD2DRD4
SCHEMBL17226056 0.92 ADH1A (0.43) ADH1ACYP1A2ADH1CDRD2DRD4
SCHEMBL627799 0.91 ADH1A (0.45) ADH1ACYP1A2ADH1CDRD2DRD4
Fluoride SCHEMBL9620624 0.89 ADH1A (0.44) ADH1ACYP1A2ADH1CDRD2DRD4
Bromide SCHEMBL28388955 0.89 ADH1A (0.44) ADH1ACYP1A2ADH1CDRD2DRD4
SCHEMBL517191 0.89 ADH1A (0.43) ADH1ACYP1A2ADH1CDRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3242872-B1 (PIPERIDIN-3-YL)(NAPHTHALEN-2-YL)METHANONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HISTONE DEMETHYLASE KDM2B FOR THE TREATMENT OF CANCER GENENTECH INC (US) 2019-07-03 EP disclosed
US-9895330-B2 IDO inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-02-20 US disclosed
EP-0986384-B1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2012-02-22 EP disclosed
EP-0986384-A4 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIV PITTSBURGH (US) 2004-09-15 EP disclosed
US-6310095-B1 INHIBITING OR TREATING CANCER, TREATING INTIMAL HYPERPLASIA ASSOCIATED WITH RESTENOSIS AND ATHEROSCLEROSIS, INHIBITING POST-TRANSLATIONAL MODIFICATION OF ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE AND/OR GERANYLGERANYLTRANSFERASE UNIVERSITY OF PITTSBURGH 2001-10-30 US disclosed
US-6248919-B1 E.G., (2S)-2-(((5-((BUTYL(2-CYCLOHEXYLETHYL)AMINO)METHYL) -2'-METHYL(1,1'-BIPHENYL)-2-YL)CARBONYL)AMINO)-4-(METHYLSULFAN YL)BUTANOIC ACID, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR PRODRUG THEREOF. ABBOTT LABORATORIES 2001-06-19 US disclosed
EP-0986384-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 2000-03-22 EP disclosed
WO-1998050029-A1 INHIBITORS OF PROTEIN ISOPRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1998-11-12 WO disclosed